"Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)".

ABSTRACT:

SUBMITTER: Rasmussen B 

PROVIDER: S-EPMC9061286 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature